Mycoplasma pneumoniae Somerson et al. (ATCC® 29343)

Strain Designations: M129-B170  /  Type Strain: no  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Strain Designations M129-B170
Respiratory research
Avirulent mutant, derived from ATCC 29342
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Medium ATCC® Medium 988: Spiroplasma medium SP-4
Growth Conditions
Max Temperature: 37.0°C
Min Temperature: 35.0°C
Atmosphere: 5% CO2
Name of Depositor WA Clyde
Avirulent mutant, derived from ATCC 29342

Lipman RP, et al. Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains. J. Bacteriol. 100: 1037-1043, 1969. PubMed: 5359607

Lipman RP, Clyde WA Jr.. The interrelationship of virulence, cytadsorption, and peroxide formation in Mycoplasma pneumoniae. Proc. Soc. Exp. Biol. Med. 131: 1163-1167, 1969. PubMed: 5811969

Collier AM, et al. Biologic effects of Mycoplasma pneumoniae and other mycoplasmas from man on hamster tracheal organ culture. Proc. Soc. Exp. Biol. Med. 132: 1153-1158, 1969. PubMed: 5391202

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation